Dose Densified Chemoimmunotherapy With Early CNS Prophylaxis in Patients Less Than 65 Years With High Risk (aaIPI at least 2) Diffuse Large B-Cell Lymphoma.

Trial Profile

Dose Densified Chemoimmunotherapy With Early CNS Prophylaxis in Patients Less Than 65 Years With High Risk (aaIPI at least 2) Diffuse Large B-Cell Lymphoma.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Dec 2016

At a glance

  • Drugs Cytarabine (Primary) ; Cyclophosphamide; Doxorubicin; Etoposide; Methotrexate; Prednisone; Rituximab; Vincristine
  • Indications Diffuse large B cell lymphoma; Follicular lymphoma
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms CHIC
  • Most Recent Events

    • 06 Dec 2016 Final results presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
    • 29 Sep 2014 Planned End Date changed from 1 Mar 2017 to 1 Dec 2017 as reported by ClinicalTrials.gov.
    • 03 Mar 2012 Company added in association field as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top